Immunoglobulin G1, anti-(human β-amyloid protofibril) (human-Mus musculus monoclonal BAN2401 heavy chain), disulfide with human-Mus musculus monoclonal BAN2401 light chain, dimer (ACI)

Poly(oxy-1,2-ethanediyl), α-(2-carboxyethyl)-ω-[2-[[(phenylmethoxy)carbonyl]amino]ethoxy]- (ACI)

Neuropeptide Y (swine), 31-L-leucine-34-L-proline- (9CI, ACI)

Tildrakizumab

Thioflavin S

Alirocumab

L-Tyrosinamide, L-lysyl-L-cysteinyl-L-asparaginyl-L-threonyl-L-alanyl-L-threonyl-L-cysteinyl-L-alanyl-L-threonyl-L-glutaminyl-L-arginyl-L-leucyl-L-alanyl-L-asparaginyl-L-phenylalanyl-L-leucyl-L-valyl-L-arginyl-L-seryl-L-seryl-L-asparaginyl-L-asparaginyl-L-leucylglycyl-L-prolyl-L-valyl-L-leucyl-L-prolyl-L-prolyl-L-threonyl-L-asparaginyl-L-valylglycyl-L-seryl-L-asparaginyl-L-threonyl-, cyclic (2→7)-disulfide (ACI)

Enoticumab

Mavrilimumab

Roledumab

Immunoglobulin G1, anti-(human hepatocyte growth factor) (human-mouse monoclonal SCH 900105 heavy chain), disulfide with human-mouse monoclonal SCH 900105 light chain, dimer (ACI)

Fasinumab

(3aR,4R,6E,9S,10E,11aR)-2,3,3a,4,5,8,9,11a-Octahydro-9-hydroxy-6,10-dimethyl-3-methylene-2-oxocyclodeca[b]furan-4-yl (2E)-4-hydroxy-2-methyl-2-butenoate (ACI)

Gantenerumab

Benralizumab

Rontalizumab

(1aR,2E,4aR,6S,7S,7aR,8R,9Z,11aS)-4a,8-Bis(acetyloxy)-9-[(acetyloxy)methyl]-7-(benzoyloxy)-1,1a,4a,5,6,7,7a,8,11,11a-decahydro-1,1,3,6-tetramethyl-4H-cyclopenta[a]cyclopropa[f]cycloundecen-4-one (ACI)

Immunoglobulin G1, anti-(human interleukin 9) (human-Mus musculus monoclonal MEDI-528 heavy chain), disulfide with human-Mus musculus monoclonal MEDI-528 κ-chain, dimer (ACI)

Racotumomab

Urelumab